Business · 26/08/1997
FDA Approves New Injectable Treatment for Canine Arthritis
The FDA has approved a new animal drug application for Luitpold Pharmaceuticals' polysulfated glycosaminoglycan injection, which will be administered intramuscularly to dogs to manage symptoms of noninfectious degenerative and/or traumatic arthritis of the canine synovial joints.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →